The introduction of this treatment in children diagnosed with neurodevelopmental disorders caused by TRPM3 variants has led to significant improvements, including enhanced EEG results, a reduction in seizure frequency up to complete cessation, and improved cognitive abilities, all without observed side effects. This evidence concerns the gene TRPM3 and neurodevelopmental disorder.